Your browser doesn't support javascript.
loading
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
Smith, Philip J; Critchley, Lisa; Storey, Daniel; Gregg, Belle; Stenson, June; Kneebone, Andrew; Rimmer, Tracy; Burke, Stevena; Hussain, Shamas; Yi Teoh, Wan; Vazeille, Stephan; Serna, Solange; Steel, Alan; Derbyshire, Edmund; Collins, Paul; Dibb, Martyn; Flanagan, Paul; Probert, Christopher; Verma, Ajay M; Subramanian, Sreedhar.
Afiliação
  • Smith PJ; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Critchley L; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Storey D; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Gregg B; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Stenson J; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Kneebone A; Department of Gastroenterology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Rimmer T; Department of Gastroenterology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Burke S; Department of Gastroenterology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Hussain S; Liverpool School of Medicine, University of Liverpool, Liverpool, UK.
  • Yi Teoh W; Liverpool School of Medicine, University of Liverpool, Liverpool, UK.
  • Vazeille S; Liverpool School of Medicine, University of Liverpool, Liverpool, UK.
  • Serna S; Department of Digestive Diseases, Kettering General Hospital, Kettering, UK.
  • Steel A; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Derbyshire E; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Collins P; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Dibb M; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Flanagan P; Department of Gastroenterology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Probert C; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Verma AM; Molecular and Cellular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Subramanian S; Department of Digestive Diseases, Kettering General Hospital, Kettering, UK.
J Crohns Colitis ; 16(9): 1436-1446, 2022 Sep 08.
Article em En | MEDLINE | ID: mdl-35390141
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Colite / Medicamentos Biossimilares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Crohns Colitis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Colite / Medicamentos Biossimilares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Crohns Colitis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido